13: Pharmacology of Reproduction Flashcards
Menstrual cycle phases
Day 1 – 13, follicular phase controlled by _____, follicle matures & estrogen is released & stimulates endometrium lining
Day 14 = ovulatory phase, _____ of ovum (LH surge stimulates ovulation)
Day 15 - 28, luteal phase, corus luteum stilulated by _____ secretes estrogen and progesterone. If no fertilization then corpus luteum degenerates corpus albicans–which cannot secrete hormones, and menses occurs.
Menstrual cycle phases
Day 1 – 13, follicular phase controlled by FSH, follicle matures & estrogen is released & stimulates endometrium lining
Day 14 = ovulatory phase, ovulation of ovum (LH surge stimulates ovulation)
Day 15 - 28, luteal phase, corus luteum stilulated by LH secretes estrogen and progesterone. If no fertilization then corpus luteum degenerates corpus albicans–which cannot secrete hormones, and menses occurs.
Low estrogen and progesterone triggers _____ release & LH & FSH which stimulates _____ to make estrogen and progesterone & when estrogen and progesterone are high they negativley feed back on GnRH
Low estrogen and progesterone triggers GnRH release & LH & FSH which stimulates ovary to make estrogen and progesterone & when estrogen and progesterone are high they negativley feed back on GnRH
Estradiol can be converted can be converted to estrone and estriol in _____.
Estrogens can also be produced in other tissues, such as adipose tissue and _____ gland in men and post-menopausal women. During pregnancy, large quantities of estriol are produced by the _____.
The major circulating estrogen in premenopausal women is _____; for men and postmenopausal women it is _____.
Estradiol can be converted can be converted to estrone and estriol in liver.
Estrogens can also be produced in other tissues, such as adipose tissue and adrenal gland in men and post-menopausal women. During pregnancy, large quantities of estriol are produced by the placenta.
The major circulating estrogen in premenopausal women is estradiol; for men and postmenopausal women it is estrone.
_____ is converted by aromatase into Estrone
_____ is converted to estriol by aromatase
Androstenedione is converted by aromatase into Estrone
Testosterone is converted to estriol by aromatase
Aromatase is involved in the production of estrogen. It converts testosterone to estradiol and androstenedione to estrone. This enzyme is expressed by estrogen producing cells of the ovaries, placenta, adrenal gland, adipose tissue, testicles and brain. It is important for estrogen biosynthesis.
_____ estrogens are used more than nonsteroidal estrogens in the clinic.
Diethylstilbestrol (DES-a Nonsteroidal synthetic estrogen) was reported to increase the risk of _____ cell adenocarcinoma in the vagina and cervix.
Steroidal estrogens are used more than nonsteroidal estrogens in the clinic.
Diethylstilbestrol (DES-a Nonsteroidal synthetic estrogen) was reported to increase the risk of clear cell adenocarcinoma in the vagina and cervix.
Estrogen binds to sex hormone binding _____.
Estrogen is hydrophobic so it crosses bilayer and binds to estrogen receptor in _____
Which then binds to estrogen response element in the _____, ERE
Estrogen binds to sex hormone binding globulin.
Estrogen is hydrophobic so it crosses bilayer and binds to estrogen receptor in cytoplasm
Which then binds to estrogen response element in the nucleus, ERE
Estrogens used in therapy are absorbed through _____, _____ membranes, and the _____ tract.
You can put estrogens up the vagina!
Estrogens are widely distributed in the body. In circulation, estradiol binds strongly to sex hormone-_____ _____ (SHBG). It also binds to albumin with lower affinity.
Estrogens used in therapy are absorbed through skin, mucous membranes, and the gastrointestinal tract.
You can put estrogens up the vagina!
Estrogens are widely distributed in the body. In circulation, estradiol binds strongly to sex hormone-binding globulin (SHBG). It also binds to albumin with lower affinity.
Estradiol (E2) is mainly metabolized in the _____ to estrone (E1).
Estradiol is not used orally frequently clinically due to the extensive _____ pass effect. Micronization _____ the half-life of estradiol and reduces its destruction in the GI tract.
If a patient has liver issues we do _____ give them estrogen.
Microlization = make estrogen into smaller particle which makes it more stable and _____ the first pass effect and _____ half-life
Estradiol (E2) is mainly metabolized in the liver to estrone (E1).
Estradiol is not used orally frequently clinically due to the extensive first pass effect. Micronization increases the half-life of estradiol and reduces its destruction in the GI tract.
If a patient has liver issues we do not give them estrogen.
Microlization = make estrogen into smaller particle which makes it more stable and lessens the first pass effect and lengthens half-life
Estrogen has positive feedback right before ovulation @ end of follicular phase. That is, estrogen has positive feedback on FSH release, but also LH surge. In contraception we give estrogen at a constant level before surge @ levels _____ between negative feedback and the positive feedback levels at the LH surge.
Estrogen has positive feedback right before ovulation @ end of follicular phase. That is, estrogen has positive feedback on FSH release, but also LH surge. In contraception we give estrogen at a constant level before surge @ levels intermediate between negative feedback and the positive feedback levels at the LH surge.
We do not give estrogen if the patient already has _____tension since _____tension is a side effect of estrogen administration.
We do not give estrogen if the patient already has hypertension since hypertension is a side effect of estrogen administration.
Estogen given with _____ supresses the risk of cervical and endometrial cancers as cervical and endometrial cancers. We do _____ give estrogen alone.
Estogen given with progestin supresses the risk of cervical and endometrial cancers as cervical and endometrial cancers. We do not give estrogen alone.
Estrogen administration is strongly _____ in patients with breast or endometrial cancer, endometriosis and undiagnosed vaginal bleeding.
Generally _____ in patients with pregnancy, thromboembolic disease, hypertension, hepatic disease or with family history of breast or uterine cancer.
Estrogen administration is strongly contraindicated in patients with breast or endometrial cancer, endometriosis and undiagnosed vaginal bleeding.
Generally contraindicated in patients with pregnancy, thromboembolic disease, hypertension, hepatic disease or with family history of breast or uterine cancer.
Tamoxifen and Clomiphene are estrogen _____ competitive antagonists (or partial agonists in some setting).
Tamoxifen and Clomiphene are estrogen receptor competitive antagonists (or partial agonists in some setting).
Tamoxifen is a _____ steroidal agent which has a strong _____ estrogenic effect on mammary epithelium & _____ estrogenic effect on uterine endometrium and bone.
Tamoxifen works as a partial estrogen competitive antagonist in the breast. It blocks estrogen from _____ to estrogen receptors (ER) and is commonly used for the treatment of ER-_____ advanced breast cancers.
Tamoxifen is a nonsteroidal agent which has a strong antiestrogenic effect on mammary epithelium & pro-estrogenic effect on uterine endometrium and bone.
Tamoxifen works as a partial estrogen competitive antagonist in the breast. It blocks estrogen from binding to estrogen receptors (ER) and is commonly used for the treatment of ER-positive advanced breast cancers.
Estrogen has much _____ binding affinity for its receptor than that of Tamoxifen. Tamoxifen must be used in a concentration much _____ than estrogen to maintain inhibition of breast cancer cells.
Prolonged use of Tamoxifen (for prevention of breast cancer) increases incidence of _____ carcinoma.
Estrogen has much higher binding affinity for its receptor than that of Tamoxifen (about 100-1,000 times higher). Tamoxifen must be used in a concentration much higher than estrogen to maintain inhibition of breast cancer cells.
Prolonged use of Tamoxifen (for prevention of breast cancer) increases incidence of endometrial carcinoma.